Human Longevity Inc

News

AstraZeneca has launched a new 'integrated genomics approach' to expand the genetic basis of its research, and aid drug discovery and development.

News

New NICE guidance means that around 90 UK women with cervical cancer should be eligible for treatment with Regeneron's Libtayo each year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.